152 related articles for article (PubMed ID: 30961685)
1. Micheliolide inhibits gastric cancer growth
Tang X; Ding Q; Chen C; Chen F; Zhou X; Hong CJ; Pan W
Pharmazie; 2019 Mar; 74(3):175-178. PubMed ID: 30961685
[TBL] [Abstract][Full Text] [Related]
2. Astragalus extract inhibits proliferation but enhances apoptosis in gastric cancer.
Wang Z; Dong L; Zhen Y; Wang Y; Qi D; Xu A; Meng X; Li W
Pak J Pharm Sci; 2016 Sep; 29(5):1473-1482. PubMed ID: 27731799
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
[TBL] [Abstract][Full Text] [Related]
4. Genipin induces mitochondrial dysfunction and apoptosis via downregulation of Stat3/mcl-1 pathway in gastric cancer.
Jo MJ; Jeong S; Yun HK; Kim DY; Kim BR; Kim JL; Na YJ; Park SH; Jeong YA; Kim BG; Ashktorab H; Smoot DT; Heo JY; Han J; Lee DH; Oh SC
BMC Cancer; 2019 Jul; 19(1):739. PubMed ID: 31351462
[TBL] [Abstract][Full Text] [Related]
5. Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6.
Xu M; Ren L; Fan J; Huang L; Zhou L; Li X; Ye X
Life Sci; 2022 Feb; 290():120266. PubMed ID: 34968467
[TBL] [Abstract][Full Text] [Related]
6. Acquisition of resistance to trastuzumab in gastric cancer cells is associated with activation of IL-6/STAT3/Jagged-1/Notch positive feedback loop.
Yang Z; Guo L; Liu D; Sun L; Chen H; Deng Q; Liu Y; Yu M; Ma Y; Guo N; Shi M
Oncotarget; 2015 Mar; 6(7):5072-87. PubMed ID: 25669984
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells by inhibiting STAT3 signaling pathway.
Huang S; Chen M; Ding X; Zhang X; Zou X
Int Immunopharmacol; 2013 Nov; 17(3):585-92. PubMed ID: 23973653
[TBL] [Abstract][Full Text] [Related]
8. Stat3-siRNA inhibits the growth of gastric cancer in vitro and in vivo.
Sun Y; Guo BF; Xu LB; Zhong JT; Liu ZW; Liang H; Wen NY; Yun WJ; Zhang L; Zhao XJ
Cell Biochem Funct; 2015 Oct; 33(7):495-502. PubMed ID: 26486443
[TBL] [Abstract][Full Text] [Related]
9. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
Pan L; Chen X; Fu S; Yu W; Li C; Wang T; Lo HW; Lin J
Breast Cancer Res Treat; 2020 May; 181(1):31-41. PubMed ID: 32240456
[TBL] [Abstract][Full Text] [Related]
10. Micheliolide inhibits LPS-induced inflammatory response and protects mice from LPS challenge.
Qin X; Jiang X; Jiang X; Wang Y; Miao Z; He W; Yang G; Lv Z; Yu Y; Zheng Y
Sci Rep; 2016 Mar; 6():23240. PubMed ID: 26984741
[TBL] [Abstract][Full Text] [Related]
11. NEK9, a novel effector of IL-6/STAT3, regulates metastasis of gastric cancer by targeting ARHGEF2 phosphorylation.
Lu G; Tian S; Sun Y; Dong J; Wang N; Zeng J; Nie Y; Wu K; Han Y; Feng B; Shang Y
Theranostics; 2021; 11(5):2460-2474. PubMed ID: 33500736
[No Abstract] [Full Text] [Related]
12. Troxerutin (TXN) potentiated 5-Fluorouracil (5-Fu) treatment of human gastric cancer through suppressing STAT3/NF-κB and Bcl-2 signaling pathways.
Xu GY; Tang XJ
Biomed Pharmacother; 2017 Aug; 92():95-107. PubMed ID: 28531805
[TBL] [Abstract][Full Text] [Related]
13. Suppression of FAK by nexrutine inhibits gastric cancer progression.
Zhuang K; Guo H; Tang H; Yan Y; Yang Z; Wang Y
Life Sci; 2020 Sep; 257():118100. PubMed ID: 32679149
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of isocryptotanshinone on gastric cancer.
Chen ZM; Huang L; Li MM; Meng L; Ying SC; Xu AM
Sci Rep; 2018 Jun; 8(1):9307. PubMed ID: 29915371
[TBL] [Abstract][Full Text] [Related]
15. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.
Chun J; Li RJ; Cheng MS; Kim YS
Cancer Lett; 2015 Feb; 357(1):393-403. PubMed ID: 25434800
[TBL] [Abstract][Full Text] [Related]
16. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
Lu S; Gao Y; Huang X; Wang X
Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
[TBL] [Abstract][Full Text] [Related]
17. [EGFR-blockade by antibody Cetuximab inhibits the growth of human gastric cancer xenograft in nude mice and its possible mechanism].
Zhang J; Ji J; Yuan F; Ma T; Ye ZB; Yu YY; Liu BY; Zhu ZG
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):85-9. PubMed ID: 19538880
[TBL] [Abstract][Full Text] [Related]
18. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
[TBL] [Abstract][Full Text] [Related]
19. Apigetrin inhibits gastric cancer progression through inducing apoptosis and regulating ROS-modulated STAT3/JAK2 pathway.
Sun Q; Lu NN; Feng L
Biochem Biophys Res Commun; 2018 Mar; 498(1):164-170. PubMed ID: 29408335
[TBL] [Abstract][Full Text] [Related]
20. miR-106b Promotes Metastasis of Early Gastric Cancer by Targeting ALEX1 in Vitro and in Vivo.
Zhu Z; Yang Q; Zhang B; Wu W; Yuan F; Zhu Z
Cell Physiol Biochem; 2019; 52(3):606-616. PubMed ID: 30907988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]